Rating History for Maze Therapeutics (MAZE) by Truist Securities

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/13/2026 Danielle Brill Maintain Buy
(N/A)
64.00
(68.00)
 
 
  Details